Pharmaceutical and Biotechnology
Pharmaceutical companies share a primary business goal of reducing time to market for new drug products. Unfortunately, the traditional processes and systems that most pharma companies use to create, store, revise, and manage content no longer serve this business goal.
Our pharma customers know that their traditional methods are holding them back. They cannot reduce time to market or increase the number of submissions without a serious transformation in how they “do” content. They need to break free of the document paradigm and adopt a structured content ecosystem.
That’s why they turn to Content Rules.
We have decades of experience guiding companies through the transformation to a structured content ecosystem that supports their business goals. We are the only end-to-end content services provider with experience in pharma.
To produce content at scale, pharma companies need:
- Content reuse
Pharma content has tremendous opportunity for content reuse and automation across the dossier and beyond. The only way to achieve reuse and automation at scale is by using structured content.
Download our white paper, The Pharma Content Evolution: Content Reuse and Automation
Content reuse eliminates redundancy from your content and processes.
Automation eliminates time-consuming manual processes that increase risks and costs.
Why Content Rules
Content Rules is the only end-to-end content services provider with decades of experience in pharmaceutical content. In fact, our very first customer is one of the top five largest pharma companies in the world. We still work with them today.
Our services include content strategy, global content strategy, content transformation, content development, and content optimization. We are experts in structured content management, content standardization, and content governance.
We’ve helped numerous customers successfully complete their content transformation from unstructured documents to structured content ecosystems. We are the only content services provider with expert knowledge of Acrolinx, Congree, and Natural Language Processing (NLP) software.
From Unstructured Documents to Structured Content
We helped a top 5 pharma company develop content models and standardize content to enable content reuse and automation within and across clinical, labeling, and CMC content.
Our content modelers worked as embedded resources within content standardization teams. We provided structured content and content reuse expertise. We also developed specifications for content standards and worked closely with the data and content standards governance teams to develop standards criteria, build automation tools, and design effective processes. Medical writers reported significant time savings and appreciated the elimination of “tedious” and “endless” rewriting from their process.
Creating the Vision and the Roadmap to Reach it
A multinational pharmaceutical and biotechnology company needed a vision and a roadmap to guide their journey from an unstructured, document-based paradigm to a structured content ecosystem.
We performed a thorough organizational needs analysis and a content audit across a large body of content. We developed a clear vision for the company to align on and a roadmap to help them get there. We spotlighted their most critical content reuse opportunities, advised them on technology requirements and capabilities, and provided customized best practices for transforming their content and processes to achieve their business goals.
Operational Efficiency Through Effective Content
The global supply division of a large pharmaceutical company based in the U.S. purchased a component-based structured content management system (SCMS). Their business goals were to streamline content operations and centralize content into a single source of truth. Previously, their manufacturing content had been created in many different places in many different file formats, including Word documents, Excel sheets, and PowerPoint decks. It was inefficient, redundant, and hard to keep current.
We facilitated working sessions to identify content reuse opportunities and design a metadata strategy. We helped them deconstruct monolithic documents into modular components and optimize those components for reuse. We then designed a content architecture they could implement in their new SCMS to maximize content reuse and automate workflows and publishing cycles.
- Content standards, content models, and reuse matrix to provide approximately 80% modular content reuse
- Variable standards and conditional logic to combine data and content and support automated content generation based on clinical trial results
- Content alignment with industry standards organizations such as CDISC, ICH, and TransCelerate
- Multi-phase plan with actionable steps to maximize ROI and ensure incremental wins
- Vision and methodology to help scale the organizational transformation
- Modular approach that emphasizes content reuse and automation
- Content models, taxonomy, and metadata model to structure content into modular components
- Reuse strategy that incorporates variables and conditional logic to extend reuse across a large body of content
- Content workflows to reduce time and effort in content creation and delivery
Content Reuse: The Only Way to Scale Pharma Content
Download our white paper to learn how content reuse and automation enable the pharmaceutical industry to reduce time to market.